Myles Wolf - Publications

Affiliations: 
Molecular Cell and Developmental Biology (Medicine) University of Miami, Coral Gables, FL 
Area:
Cell Biology, Molecular Biology

203/345 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Edmonston D, Fuchs MAA, Burke EJ, Isakova T, Wolf M. Klotho and Clinical Outcomes in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 38583756 DOI: 10.1053/j.ajkd.2024.02.008  0.302
2023 Sohn MB, Gao B, Kendrick C, Srivastava A, Isakova T, Gassman JJ, Fried LF, Wolf M, Cheung AK, Raphael KL, Vinales PC, Middleton JP, Pabalan A, Raj DS. Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study. Kidney International Reports. 9: 671-685. PMID 38481512 DOI: 10.1016/j.ekir.2023.12.017  0.31
2023 Leidner AS, Cai X, Zelnick LR, Lee J, Bansal N, Pasch A, Kansal M, Chen J, Anderson AH, Sondheimer JH, Lash JP, Townsend RR, Go AS, Feldman HI, Shah SJ, ... Wolf M, et al. Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study. Kidney Medicine. 5: 100723. PMID 37915961 DOI: 10.1016/j.xkme.2023.100723  0.347
2023 Wolf M. FGF23 AND ALTERED MINERAL HOMEOSTASIS IN KIDNEY DISEASE AND FOLLOWING INTRAVENOUS IRON. Transactions of the American Clinical and Climatological Association. 133: 262-273. PMID 37701608  0.402
2023 Edmonston D, Grabner A, Wolf M. FGF23 and klotho at the intersection of kidney and cardiovascular disease. Nature Reviews. Cardiology. PMID 37443358 DOI: 10.1038/s41569-023-00903-0  0.422
2023 Sunderraj A, Wong M, Gutiérrez OM, Wolf M, Akhabue E, Carnethon MR, Yancy CW, Isakova T. Associations of FGF23 with 10-year change in eGFR and UACR with incident CKD in the CARDIA cohort. Kidney360. PMID 37265357 DOI: 10.34067/KID.0000000000000172  0.359
2022 Fujii N, Hamano T, Hsu JY, Imai E, Akizawa T, Nitta K, Watanabe T, Iimuro S, Ohashi Y, Matsuo S, Makino H, Hishida A, Alper AB, Horwitz EJ, Hsu CY, ... ... Wolf M, et al. A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan. American Journal of Nephrology. 1-14. PMID 35226897 DOI: 10.1159/000521386  0.34
2021 Akhabue E, Wong M, Mehta R, Isakova T, Wolf M, Yancy C, Gutierrez OM, Carnethon M. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study. American Heart Journal. 245: 10-18. PMID 34861237 DOI: 10.1016/j.ahj.2021.11.009  0.329
2021 Courbon G, Francis C, Gerber C, Neuburg S, Wang X, Lynch E, Isakova T, Babitt JL, Wolf M, Martin A, David V. Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease. Bone Research. 9: 35. PMID 34334787 DOI: 10.1038/s41413-021-00154-0  0.375
2020 Kula AJ, Katz R, Zelnick LR, Soliman E, Go A, Shlipak M, Deo R, Ky B, DeBoer I, Anderson A, Christenson R, Seliger SL, Defilippi C, Feldman HI, Wolf M, et al. Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 33367652 DOI: 10.1093/ndt/gfaa296  0.322
2020 Saraf SL, Hsu JY, Ricardo AC, Mehta R, Chen J, Chen TK, Fischer MJ, Hamm L, Sondheimer J, Weir MR, Zhang X, Wolf M, Lash JP. Anemia and Incident End-Stage Kidney Disease. Kidney360. 1: 623-630. PMID 33117990 DOI: 10.34067/Kid.0000852020  0.429
2020 Gitomer B, Pereira R, Salusky IB, Stoneback JW, Isakova T, Cai X, Dalrymple LS, Ofsthun N, You Z, Malluche HH, Maddux F, George D, Torres V, Chapman A, Steinman TI, ... Wolf M, et al. Mineral bone disease in autosomal dominant polycystic kidney disease. Kidney International. PMID 32926884 DOI: 10.1016/J.Kint.2020.07.041  0.389
2020 Anderson AH, Xie D, Wang X, Baudier RL, Orlandi P, Appel LJ, Dember LM, He J, Kusek JW, Lash JP, Navaneethan SD, Ojo A, Rahman M, Roy J, Scialla JJ, ... ... Wolf M, et al. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 32866540 DOI: 10.1053/J.Ajkd.2020.07.011  0.414
2020 Edmonston DL, Roe MT, Block G, Conway PT, Dember LM, DiBattiste PM, Greene T, Hariri A, Inker LA, Isakova T, Montez-Rath ME, Nkulikiyinka R, Polidori D, Roessig L, Tangri N, ... ... Wolf M, et al. Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 32768631 DOI: 10.1053/J.Ajkd.2020.05.026  0.331
2020 Frazier R, Hodakowski A, Cai X, Lee J, Zakarija A, Stein B, David V, Wolf M, Isakova T, Mehta R. Effects of ferric carboxymaltose on markers of mineral and bone metabolism: a single-center prospective observational study of women with iron deficiency. Bone. 115559. PMID 32730929 DOI: 10.1016/J.Bone.2020.115559  0.343
2020 Florenzano P, Jimenez M, Ferreira CR, Nesterova G, Roberts MS, Tella SH, Fernandez de Castro L, Gafni RI, Wolf M, Jüppner H, Gales B, Wesseling-Perry K, Markovich D, Gahl WA, Salusky IB, et al. Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23. Journal of the American Society of Nephrology : Jasn. PMID 32631973 DOI: 10.1681/Asn.2019111172  0.361
2020 Ishigami J, Taliercio JT, Feldman HI, Srivastava A, Townsend RR, Cohen DL, Horwitz EJ, Rao P, Charleston J, Fink JC, Ricardo AC, Sondheimer J, Chen TK, Wolf M, Isakova T, et al. Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology : Jasn. PMID 32576601 DOI: 10.1681/Asn.2019101106  0.478
2020 Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting Vascular Calcification in Chronic Kidney Disease. Jacc. Basic to Translational Science. 5: 398-412. PMID 32368697 DOI: 10.1016/J.Jacbts.2020.02.002  0.438
2020 Srivastava A, Cai X, Lee J, Li W, Larive B, Kendrick C, Gassman JJ, Middleton JP, Carr J, Raphael KL, Cheung AK, Raj DS, Chonchol MB, Fried LF, Block GA, ... ... Wolf M, et al. Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 32345747 DOI: 10.2215/Cjn.13201019  0.324
2020 Anand S, Jagannathan R, Gupta R, Mohan S, Prabhakaran D, Wolf M. Fibroblast Growth Factor-23 and a Vegetarian Diet. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. PMID 32247648 DOI: 10.1053/J.Jrn.2020.02.004  0.356
2020 Wolf M, Block GA, Chertow GM, Cooper K, Fouqueray B, Moe SM, Sun Y, Tomlin H, Vervloet M, Oberbauer R. Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis. Clinical Kidney Journal. 13: 75-84. PMID 32082556 DOI: 10.1093/Ckj/Sfz034  0.38
2020 Grabner A, Wolf M. Kidney to bone via bedside to bench…and back? The Journal of Clinical Investigation. PMID 32065594 DOI: 10.1172/Jci135213  0.407
2020 Willey JZ, Moon YP, Husain SA, Elkind MSV, Sacco RL, Wolf M, Cheung K, Wright CB, Mohan S. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study. Plos One. 15: e0226509. PMID 31940363 DOI: 10.1371/Journal.Pone.0226509  0.351
2019 Bansal N, Katz R, Appel L, Denburg M, Feldman H, Go AS, He J, Hoofnagle A, Isakova T, Kestenbaum B, Kusek J, Lash J, Leonard M, Rahman M, Robinson-Cohen C, ... Wolf M, et al. Vitamin D Metabolic Ratio and Risks of Death and CKD Progression. Kidney International Reports. 4: 1598-1607. PMID 31891001 DOI: 10.1016/J.Ekir.2019.08.014  0.389
2019 Mehta R, Cai X, Lee J, Xie D, Wang X, Scialla J, Anderson AH, Taliercio J, Dobre M, Chen J, Fischer M, Leonard M, Lash J, Hsu CY, de Boer IH, ... ... Wolf M, et al. Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 31864822 DOI: 10.1053/J.Ajkd.2019.09.009  0.498
2019 Raphael KL, Isakova T, Ix JH, Raj DS, Wolf M, Fried LF, Gassman JJ, Kendrick C, Larive B, Flessner MF, Mendley SR, Hostetter TH, Block GA, Li P, Middleton JP, et al. A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial. Journal of the American Society of Nephrology : Jasn. PMID 31848294 DOI: 10.1681/Asn.2019030287  0.305
2019 Musgrove J, Wolf M. Regulation and Effects of FGF23 in Chronic Kidney Disease. Annual Review of Physiology. PMID 31743079 DOI: 10.1146/Annurev-Physiol-021119-034650  0.488
2019 Edmonston DL, Parikh KS, Rajagopal S, Shaw LK, Abraham D, Grabner A, Sparks MA, Wolf M. Pulmonary Hypertension Subtypes and Mortality in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 31732231 DOI: 10.1053/J.Ajkd.2019.08.027  0.39
2019 Ishigami J, Taliercio J, Feldman H, Srivastava A, Townsend R, Cohen D, Horwitz E, Rao P, Charleston J, Fink JC, Ricardo AC, Sondheimer J, Chen TK, Wolf M, Isakova T, et al. Inflammatory Markers and Incidence of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Epidemiology. PMID 31673705 DOI: 10.1093/Aje/Kwz246  0.308
2019 Francis C, Courbon G, Gerber C, Neuburg S, Wang X, Dussold C, Capella M, Qi L, Isakova T, Mehta R, Martin A, Wolf M, David V. Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease. Kidney International. PMID 31668632 DOI: 10.1016/J.Kint.2019.07.026  0.462
2019 Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, Nessel L, Anderson AH, Lo J, Porter A, Nunes JW, Negrea L, Hamm L, Horwitz E, Chen J, ... ... Wolf M, et al. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 31668375 DOI: 10.1053/J.Ajkd.2019.07.022  0.404
2019 Emrich IE, Dederer J, Kircher A, Klemis V, Lennartz CS, Untersteller K, Wagenpfeil S, Fliser D, Wolf M, Heine GH. Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet? Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. PMID 31653518 DOI: 10.1016/J.Numecd.2019.09.002  0.343
2019 Taylor A, Yanucil C, Musgrove J, Shi M, Ide S, Souma T, Faul C, Wolf M, Grabner A. FGFR4 does not contribute to progression of chronic kidney disease. Scientific Reports. 9: 14023. PMID 31575945 DOI: 10.1038/S41598-019-50669-0  0.513
2019 Edmonston D, Wolf M. FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nature Reviews. Nephrology. PMID 31519999 DOI: 10.1038/S41581-019-0189-5  0.399
2019 Edmonston D, Wojdyla D, Mehta R, Cai X, Lora C, Cohen D, Townsend RR, He J, Go AS, Kusek J, Weir MR, Isakova T, Pencina M, Wolf M. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 31445926 DOI: 10.1053/J.Ajkd.2019.05.026  0.426
2019 Block GA, Block MS, Smits G, Mehta R, Isakova T, Wolf M, Chertow GM. A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. Journal of the American Society of Nephrology : Jasn. PMID 31278194 DOI: 10.1681/Asn.2018101016  0.408
2019 Canney M, Djurdjev O, Tang M, Zierold C, Blocki F, Wolf M, Levin A. GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease. American Journal of Nephrology. 1-10. PMID 31238301 DOI: 10.1159/000501189  0.499
2019 Yokoyama K, Fukagawa M, Akiba T, Nakayama M, Ito K, Hanaki K, Wolf M, Hirakata H. Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study. Scientific Reports. 9: 8877. PMID 31222044 DOI: 10.1038/S41598-019-45335-4  0.335
2019 Paluch AE, Pool LR, Isakova T, Lewis CE, Mehta R, Schreiner PJ, Sidney S, Wolf M, Carnethon MR. Association of Fitness With Racial Differences in Chronic Kidney Disease. American Journal of Preventive Medicine. PMID 31122794 DOI: 10.1016/J.Amepre.2019.02.016  0.423
2019 Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK, Sprague SM, Fried LF, Gassman JJ, Middleton JP, Flessner MF, Block GA, Wolf M. Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial. Journal of the American Society of Nephrology : Jasn. PMID 31085679 DOI: 10.1681/Asn.2018101058  0.468
2019 Dussold C, Gerber C, White S, Wang X, Qi L, Francis C, Capella M, Courbon G, Wang J, Li C, Feng JQ, Isakova T, Wolf M, David V, Martin A. DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease. Bone Research. 7: 12. PMID 31044094 DOI: 10.1038/S41413-019-0051-1  0.448
2019 Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, Leonard MB, Go AS, Rao PS, Lash JP, Townsend RR, Feldman HI, de Boer IH, Block GA, Wolf M, et al. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 30935773 DOI: 10.1053/J.Ajkd.2019.01.024  0.44
2019 Brown L, Luciano A, Pendergast J, Khairallah P, Anderson CAM, Sondheimer J, Hamm LL, Ricardo AC, Rao P, Rahman M, Miller ER, Sha D, Xie D, Feldman HI, Asplin J, ... Wolf M, et al. Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 30910373 DOI: 10.1053/J.Ajkd.2018.12.043  0.413
2019 Jovanovich A, You Z, Isakova T, Nowak K, Cheung A, Wolf M, Chonchol M, Kendrick J. Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study. American Journal of Nephrology. 49: 263-270. PMID 30820005 DOI: 10.1159/000497445  0.377
2019 Lunyera J, Davenport CA, Pendergast J, Musani SK, Bhavsar NA, Sims M, Mwasongwe S, Wolf M, Diamantidis CJ, Boulware LE, Scialla JJ. Modifiers of Plasma 25-hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study. The Journal of Clinical Endocrinology and Metabolism. PMID 30668751 DOI: 10.1210/Jc.2018-01747  0.335
2019 Iqbal T, Wolf M, Muckadell PSd, Zoller H. PTH-137 Phosphare studies: important changes in phosphate homeostasis and bone metabolism after IV iron Gut. 68. DOI: 10.1136/Gutjnl-2019-Bsgabstracts.196  0.357
2018 Amdur RL, Feldman HI, Dominic EA, Anderson AH, Beddhu S, Rahman M, Wolf M, Reilly M, Ojo A, Townsend RR, Go AS, He J, Xie D, Thompson S, Budoff M, et al. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 30545708 DOI: 10.1053/J.Ajkd.2018.09.012  0.412
2018 Husain SA, Willey JZ, Park Moon Y, Elkind MSV, Sacco RL, Wolf M, Cheung K, Wright CB, Mohan S. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study. Plos One. 13: e0206839. PMID 30427947 DOI: 10.1371/Journal.Pone.0206839  0.359
2018 Akhabue E, Vu TT, Vaidya A, Michos ED, de Boer IH, Kestenbaum B, Allison M, Szklo M, Ouyang P, Yancy CW, Wolf M, Isakova T, Carnethon MR. Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The Multi-Ethnic Study of Atherosclerosis. American Journal of Hypertension. PMID 30256890 DOI: 10.1093/Ajh/Hpy142  0.373
2018 Robinson-Cohen C, Bartz TM, Lai D, Ikizler TA, Peacock M, Imel EA, Michos ED, Foroud TM, Akesson K, Taylor KD, Malmgren L, Matsushita K, Nethander M, Eriksson J, Ohlsson C, ... ... Wolf M, et al. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. Journal of the American Society of Nephrology : Jasn. PMID 30217807 DOI: 10.1681/Asn.2018020192  0.398
2018 Marebwa BK, Adams RJ, Magwood GS, Kindy M, Wilmskoetter J, Wolf M, Bonilha L. Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes. Plos One. 13: e0203460. PMID 30192823 DOI: 10.1371/Journal.Pone.0203460  0.409
2018 Mehta R, Cai X, Hodakowski A, Thyagarajan B, Zeng D, Zee PC, Wohlgemuth WK, Redline S, Lash JP, Wolf M, Isakova T. Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos. Bone. 114: 278-284. PMID 29986841 DOI: 10.1016/J.Bone.2018.06.024  0.336
2018 Scialla JJ, Brown L, Gurley S, Corcoran DL, Bain JR, Muehlbauer MJ, O'Neal SK, M O'Connell T, Wolf M, Melamed ML, Hostetter TH, Abramowitz MK. Metabolic Changes with Base-Loading in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29934431 DOI: 10.2215/Cjn.01830218  0.383
2018 Akhabue E, Montag S, Reis JP, Pool LR, Mehta R, Yancy CW, Zhao L, Wolf M, Gutierrez OM, Carnethon MR, Isakova T. FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study (Coronary Artery Risk Development in Young Adults). Hypertension (Dallas, Tex. : 1979). PMID 29712737 DOI: 10.1161/Hypertensionaha.118.11060  0.364
2018 Block GA, Rosenbaum DP, Yan A, Greasley PJ, Chertow GM, Wolf M. The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 29617976 DOI: 10.1093/Ndt/Gfy061  0.419
2018 Leaf DE, Siew ED, Eisenga MF, Singh K, Mc Causland FR, Srivastava A, Ikizler TA, Ware LB, Ginde AA, Kellum JA, Palevsky PM, Wolf M, Waikar SS. Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29519954 DOI: 10.2215/Cjn.10810917  0.388
2018 Vervloet M, Cooper K, Block G, Chertow G, Fouqueray B, Moe S, Sun Y, Tomlin H, Wolf M, Oberbauer R. Fp378Baseline Levels Of Fgf23 And Effects Of Etelcalcetide Nephrology Dialysis Transplantation. 33. DOI: 10.1093/Ndt/Gfy104.Fp378  0.336
2018 Canney M, Djurdjev O, Tang M, Zierold C, Blocki F, Bonelli F, Wolf M, Levin A. FP377NOVEL RISK-BASED THRESHOLDS FOR BONE MINERAL BIOMARKERS IN ADVANCED CKD Nephrology Dialysis Transplantation. 33: i159-i159. DOI: 10.1093/Ndt/Gfy104.Fp377  0.313
2017 Neuburg S, Dussold C, Gerber C, Wang X, Francis C, Qi L, David V, Wolf M, Martin A. Genetic background influences cardiac phenotype in murine chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 29309658 DOI: 10.1093/Ndt/Gfx332  0.487
2017 Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, Allen NB, Scialla JJ, Pencina MJ, Anderson AH, Talierco J, Chen J, Fischer MJ, Steigerwalt SP, Leonard MB, ... ... Wolf M, et al. Longitudinal FGF23 Trajectories and Mortality in Patients with CKD. Journal of the American Society of Nephrology : Jasn. PMID 29167351 DOI: 10.1681/Asn.2017070772  0.422
2017 Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA. FGF23 and Left Ventricular Hypertrophy in Children with CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29025789 DOI: 10.2215/CJN.02110217  0.307
2017 Mehta R, Cai X, Hodakowski A, Lee J, Leonard M, Ricardo A, Chen J, Hamm L, Sondheimer J, Dobre M, David V, Yang W, Go A, Kusek JW, Feldman H, ... Wolf M, et al. Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 28784656 DOI: 10.2215/Cjn.03950417  0.481
2017 Pool LR, Wolf M. FGF23 and Nutritional Metabolism. Annual Review of Nutrition. PMID 28715994 DOI: 10.1146/Annurev-Nutr-071816-064620  0.416
2017 Chonchol M, Gitomer B, Isakova T, Cai X, Salusky I, Pereira R, Abebe K, Torres V, Steinman TI, Grantham JJ, Chapman AB, Schrier RW, Wolf M. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 28705885 DOI: 10.2215/Cjn.12821216  0.337
2017 Khairallah P, Isakova T, Asplin J, Hamm L, Dobre M, Rahman M, Sharma K, Leonard M, Miller E, Jaar B, Brecklin C, Yang W, Wang X, Feldman H, Wolf M, et al. Acid Load and Phosphorus Homeostasis in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 28645705 DOI: 10.1053/J.Ajkd.2017.04.022  0.398
2017 He J, Shlipak M, Anderson A, Roy JA, Feldman HI, Kallem RR, Kanthety R, Kusek JW, Ojo A, Rahman M, Ricardo AC, Soliman EZ, Wolf M, Zhang X, Raj D, et al. Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. Journal of the American Heart Association. 6. PMID 28515118 DOI: 10.1161/Jaha.116.005336  0.405
2017 Grabner A, Schramm K, Silswal N, Hendrix M, Yanucil C, Czaya B, Singh S, Wolf M, Hermann S, Stypmann J, Di Marco GS, Brand M, Wacker MJ, Faul C. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. Scientific Reports. 7: 1993. PMID 28512310 DOI: 10.1038/S41598-017-02068-6  0.419
2017 Ahmad FS, Cai X, Kunkel K, Ricardo AC, Lash JP, Raj DS, He J, Anderson AH, Budoff MJ, Wright Nunes JA, Roy J, Wright JT, Go AS, St John Sutton MG, Kusek JW, ... ... Wolf M, et al. Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort. American Journal of Hypertension. PMID 28444108 DOI: 10.1093/Ajh/Hpx058  0.441
2017 Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, Zhang X, Roy JA, Lustigova E, Nessel L, Ford V, Raj D, Porter AC, Soliman EZ, Wright JT, ... Wolf M, et al. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. Jama Cardiology. PMID 28329057 DOI: 10.1001/Jamacardio.2017.0363  0.407
2017 Hsu JY, Roy JA, Xie D, Yang W, Shou H, Anderson AH, Landis JR, Jepson C, Wolf M, Isakova T, Rahman M, Feldman HI. Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 28242844 DOI: 10.2215/Cjn.10301016  0.376
2017 Resende AL, Elias RM, Wolf M, Dos Reis LM, Graciolli FG, Santos GD, Dias CB, Jorgetti V, Woronik V, Moysés RM. Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis. Cytokine. 91: 124-127. PMID 28063327 DOI: 10.1016/J.Cyto.2016.12.022  0.438
2017 Wolf M, Block G, Chertow G, Cooper K, Fouqueray B, Moe S, Sun Y, Tomlin H, Vervloet M, Oberbauer R. SO033IMPACT OF ETELCALCETIDE ON FGF23 LEVELS DURING THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON HEMODIALYSIS Nephrology Dialysis Transplantation. 32: iii20-iii20. DOI: 10.1093/Ndt/Gfx105.So033  0.332
2016 Leaf DE, Jacob KA, Srivastava A, Chen ME, Christov M, Jüppner H, Sabbisetti VS, Martin A, Wolf M, Waikar SS. Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness. Journal of the American Society of Nephrology : Jasn. PMID 28028134 DOI: 10.1681/Asn.2016080836  0.412
2016 Pichler G, Haller MC, Kainz A, Wolf M, Redon J, Oberbauer R. Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 28025385 DOI: 10.1093/Ndt/Gfw387  0.385
2016 Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, ... ... Wolf M, et al. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. Kidney International. PMID 28017325 DOI: 10.1016/J.Kint.2016.10.021  0.485
2016 Bonato FO, Watanabe R, Lemos MM, Cassiolato JL, Wolf M, Canziani ME. Asymptomatic Ventricular Arrhythmia and Clinical Outcomes in Chronic Kidney Disease: A Pilot Study. Cardiorenal Medicine. 7: 66-73. PMID 27994604 DOI: 10.1159/000449260  0.429
2016 Kosk D, Kramer H, Luke A, Camacho P, Bovet P, Rhule JP, Forrester T, Wolf M, Sempos C, Melamed ML, Dugas LR, Cooper R, Durazo-Arvizu R. Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry. Journal of Bone and Mineral Metabolism. PMID 27942978 DOI: 10.1007/S00774-016-0804-5  0.397
2016 Scialla JJ, Asplin J, Dobre M, Chang AR, Lash J, Hsu CY, Kallem RR, Hamm LL, Feldman HI, Chen J, Appel LJ, Anderson CA, Wolf M. Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. Kidney International. PMID 27914710 DOI: 10.1016/J.Kint.2016.09.012  0.369
2016 Souma N, Isakova T, Lipiszko D, Sacco RL, Elkind MS, DeRosa JT, Silverberg SJ, Mendez AJ, Dong C, Wright CB, Wolf M. Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study. The Journal of Clinical Endocrinology and Metabolism. jc20162215. PMID 27501282 DOI: 10.1210/Jc.2016-2215  0.42
2016 Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S, Czaja MJ, Bartz R, Abraham R, Di Marco GS, Brand M, Wolf M, Faul C. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney International. PMID 27457912 DOI: 10.1016/J.Kint.2016.05.019  0.339
2016 Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, ... Wolf M, et al. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. Jama Cardiology. PMID 27434583 DOI: 10.1001/Jamacardio.2016.1445  0.489
2016 Lash JP, Ricardo AC, Roy J, Deo R, Fischer M, Flack J, He J, Keane M, Lora C, Ojo A, Rahman M, Steigerwalt S, Tao K, Wolf M, Wright JT, et al. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27209443 DOI: 10.1053/J.Ajkd.2016.03.429  0.422
2016 Bansal N, Xie D, Tao K, Chen J, Deo R, Horwitz E, Hsu CY, Kallem RK, Keane MG, Lora CM, Raj D, Soliman EZ, Strauss L, Wolf M, Go AS, et al. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 27073197 DOI: 10.2215/Cjn.10921015  0.364
2016 Wright CB, Shah NH, Mendez AJ, DeRosa JT, Yoshita M, Elkind MS, Sacco RL, DeCarli C, Rundek T, Silverberg S, Dong C, Wolf M. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study. Stroke; a Journal of Cerebral Circulation. PMID 26956260 DOI: 10.1161/Strokeaha.115.012379  0.38
2016 Leaf DE, Christov M, Jüppner H, Siew E, Ikizler TA, Bian A, Chen G, Sabbisetti VS, Bonventre JV, Cai X, Wolf M, Waikar SS. Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery. Kidney International. PMID 26924052 DOI: 10.1016/J.Kint.2015.12.035  0.446
2016 Gutiérrez OM, Parsa A, Isakova T, Scialla JJ, Chen J, Flack JM, Nessel LC, Gupta J, Bellovich KA, Steigerwalt S, Sondheimer JH, Wright JT, Feldman HI, Kusek JW, Lash JP, ... Wolf M, et al. Genetic African Ancestry and Markers of Mineral Metabolism in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26912553 DOI: 10.2215/Cjn.08020715  0.388
2016 Ali FN, Josefson J, Mendez AJ, Mestan K, Wolf M. Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates. The Journal of Clinical Endocrinology and Metabolism. jc20153709. PMID 26859104 DOI: 10.1210/Jc.2015-3709  0.411
2016 David V, Wolf M. Pruning the ricket thicket. The Journal of Clinical Investigation. 1-4. PMID 26784540 DOI: 10.1172/Jci85005  0.397
2016 Wald R, Goldstein MB, Perl J, Kiaii M, Yuen D, Wald RM, Harel Z, Weinstein JJ, Jakubovic B, Leong-Poi H, Kirpalani A, Leipsic J, Dacouris N, Wolf M, Yan AT. The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease. The Canadian Journal of Cardiology. 32: 369-77. PMID 26386732 DOI: 10.1016/J.Cjca.2015.07.004  0.399
2015 Suarez JJ, Isakova T, Anderson CA, Boulware LE, Wolf M, Scialla JJ. Food Access, Chronic Kidney Disease, and Hypertension in the U.S. American Journal of Preventive Medicine. 49: 912-920. PMID 26590940 DOI: 10.1016/J.Amepre.2015.07.017  0.367
2015 David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney International. PMID 26535997 DOI: 10.1038/Ki.2015.290  0.418
2015 Wolf M, Mehta R. Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney Failure. Jacc. Heart Failure. 3: 840-2. PMID 26450002 DOI: 10.1016/J.Jchf.2015.07.008  0.402
2015 Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, Martin A, Fornoni A, Di Marco GS, Kentrup D, Reuter S, ... ... Wolf M, et al. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Cell Metabolism. PMID 26437603 DOI: 10.1016/J.Cmet.2015.09.002  0.749
2015 Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26430087 DOI: 10.2215/Cjn.05220515  0.377
2015 Scialla JJ, Wolf M. When there will never be a randomized controlled trial. Kidney International. 88: 220-2. PMID 26230199 DOI: 10.1038/Ki.2015.123  0.348
2015 Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Transplantation. PMID 26177089 DOI: 10.1097/Tp.0000000000000823  0.363
2015 Shah NH, Dong C, Elkind MS, Sacco RL, Mendez AJ, Hudson BI, Silverberg S, Wolf M, Rundek T, Wright CB. Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26112008 DOI: 10.1161/Atvbaha.115.305945  0.423
2015 Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA. Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. Journal of the American Society of Nephrology : Jasn. PMID 25967123 DOI: 10.1681/Asn.2015020117  0.49
2015 Mehta R, Ying GS, Houston S, Isakova T, Nessel L, Ojo A, Go A, Lash J, Kusek J, Grunwald J, Wolf M. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 25910495 DOI: 10.1093/Ndt/Gfv123  0.514
2015 Dobre M, Yang W, Pan Q, Appel L, Bellovich K, Chen J, Feldman H, Fischer MJ, Ham LL, Hostetter T, Jaar BG, Kallem RR, Rosas SE, Scialla JJ, Wolf M, et al. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study. Journal of the American Heart Association. 4. PMID 25896890 DOI: 10.1161/Jaha.114.001599  0.46
2015 Da J, Xie X, Wolf M, Disthabanchong S, Wang J, Zha Y, Lv J, Zhang L, Wang H. Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 25804679 DOI: 10.1053/J.Ajkd.2015.01.009  0.441
2015 Block GA, Fishbane S, Rodriguez M, Smits G, Shemesh S, Pergola PE, Wolf M, Chertow GM. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 65: 728-36. PMID 25468387 DOI: 10.1053/J.Ajkd.2014.10.014  0.388
2015 Eckberg K, Kramer H, Wolf M, Durazo-Arvizu R, Tayo B, Luke A, Cooper R. Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: 630-5. PMID 25358495 DOI: 10.1093/Ndt/Gfu342  0.413
2015 Isakova T, Craven TE, Lee J, Scialla JJ, Xie H, Wahl P, Marcovina SM, Byington RP, Wolf M. Fibroblast growth factor 23 and incident CKD in type 2 diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 10: 29-38. PMID 25343949 DOI: 10.2215/Cjn.06190614  0.44
2015 Hu MC, Shi M, Cho HJ, Adams-Huet B, Paek J, Hill K, Shelton J, Amaral AP, Faul C, Taniguchi M, Wolf M, Brand M, Takahashi M, Kuro-O M, Hill JA, et al. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. Journal of the American Society of Nephrology : Jasn. 26: 1290-302. PMID 25326585 DOI: 10.1681/Asn.2014050465  0.699
2015 Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, Dries DL, Go AS, He J, Kusek JW, Lash JP, Raj D, Rosas S, Wolf M, Zhang X, et al. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology : Jasn. 26: 946-56. PMID 25278510 DOI: 10.1681/Asn.2014010108  0.414
2015 Wolf M. The biomarker niche for fibroblast growth factor 23 testing in CKD. Journal of the American Society of Nephrology : Jasn. 26: 7-9. PMID 25060055 DOI: 10.1681/Asn.2014060621  0.396
2015 Grabner A, Amaral A, Singh S, Schramm K, Sloan A, Kentrup D, Reuter S, Pavenstaedt H, Marco GSD, Wolf M, Brand M, Faul C. SaO027CARDIO-PATHOLOGICAL EFFECTS OF FGF23 IN CKD ARE MEDIATED BY FGFR4 Nephrology Dialysis Transplantation. 30. DOI: 10.1093/Ndt/Gfv150.04  0.739
2014 Di Marco GS, Reuter S, Kentrup D, Grabner A, Amaral AP, Fobker M, Stypmann J, Pavenstädt H, Wolf M, Faul C, Brand M. Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 29: 2028-35. PMID 24875663 DOI: 10.1093/Ndt/Gfu190  0.704
2014 Wolf M, White KE. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Current Opinion in Nephrology and Hypertension. 23: 411-9. PMID 24867675 DOI: 10.1097/01.Mnh.0000447020.74593.6F  0.495
2014 Bernstein EJ, Isakova T, Sullivan ME, Chibnik LB, Wolf M, Kay J. Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study. Rheumatology (Oxford, England). 53: 1613-7. PMID 24706993 DOI: 10.1093/rheumatology/keu151  0.313
2014 Wright CB, Dong C, Stark M, Silverberg S, Rundek T, Elkind MS, Sacco RL, Mendez A, Wolf M. Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). Neurology. 82: 1700-6. PMID 24706015 DOI: 10.1212/Wnl.0000000000000410  0.333
2014 Scialla JJ, Wolf M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nature Reviews. Nephrology. 10: 268-78. PMID 24686452 DOI: 10.1038/Nrneph.2014.49  0.488
2014 Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, Raj DS, Yang W, He J, Lash JP, Go AS, ... ... Wolf M, et al. Fibroblast growth factor-23 and cardiovascular events in CKD. Journal of the American Society of Nephrology : Jasn. 25: 349-60. PMID 24158986 DOI: 10.1681/Asn.2013050465  0.436
2014 Ferreira G, Guerra G, Schiavenato E, Agena F, Moyses R, David-Neto E, Wolf M. Bone and Mineral Metabolism and Fibroblast Growth Factor 23 Levels After Kidney Donation.: Abstract# A318 Transplantation. 98: 491. DOI: 10.1097/00007890-201407151-01635  0.348
2014 Kurnatowska I, Grzelak P, Masajtis-Zagajewska A, Kaczmarska M, Stefańczyk L, Vermeer C, Maresz K, Nowicki M, Patel L, Bernard LM, Elder GJ, Leonardis D, Mallamaci F, Tripepi G, D'Arrigo G, ... ... Wolf M, et al. Ckd Pathophysiology And Clinical Studies Nephrology Dialysis Transplantation. 29. DOI: 10.1093/Ndt/Gfu148  0.323
2013 Dubin RF, Li Y, He J, Jaar BG, Kallem R, Lash JP, Makos G, Rosas SE, Soliman EZ, Townsend RR, Yang W, Go AS, Keane M, Defilippi C, Mishra R, ... Wolf M, et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). Bmc Nephrology. 14: 229. PMID 24148285 DOI: 10.1186/1471-2369-14-229  0.382
2013 Block GA, Ix JH, Ketteler M, Martin KJ, Thadhani RI, Tonelli M, Wolf M, Jüppner H, Hruska K, Wheeler DC. Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 62: 457-73. PMID 23763855 DOI: 10.1053/J.Ajkd.2013.03.042  0.451
2013 Ky B, Shults J, Keane MG, Sutton MS, Wolf M, Feldman HI, Reese PP, Anderson CA, Townsend RR, Deo R, Lo J, Gadegbeku C, Carlow D, Sulik MJ, Leonard MB, et al. FGF23 modifies the relationship between vitamin D and cardiac remodeling. Circulation. Heart Failure. 6: 817-24. PMID 23748358 DOI: 10.1161/Circheartfailure.112.000105  0.327
2013 Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, Wolf M, Jüppner H. Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney International. 84: 776-85. PMID 23657144 DOI: 10.1038/Ki.2013.150  0.422
2013 Evenepoel P, Wolf M. A balanced view of calcium and phosphate homeostasis in chronic kidney disease. Kidney International. 83: 789-91. PMID 23633052 DOI: 10.1038/Ki.2013.21  0.43
2013 Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 62: 670-8. PMID 23489677 DOI: 10.1053/J.Ajkd.2013.01.017  0.471
2013 Isakova T, Barchi-Chung A, Enfield G, Smith K, Vargas G, Houston J, Xie H, Wahl P, Schiavenato E, Dosch A, Gutiérrez OM, Diego J, Lenz O, Contreras G, Mendez A, ... ... Wolf M, et al. Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. 8: 1009-18. PMID 23471131 DOI: 10.2215/Cjn.09250912  0.472
2013 Leaf DE, Waikar SS, Wolf M, Cremers S, Bhan I, Stern L. Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes. Clinical Endocrinology. 79: 491-8. PMID 23414198 DOI: 10.1111/Cen.12172  0.427
2013 Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP, Hamano T, Master SR, Nessel L, Chai B, Xie D, ... ... Wolf M, et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney International. 83: 1159-68. PMID 23389416 DOI: 10.1038/Ki.2013.3  0.735
2013 Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M. Mineral metabolites and CKD progression in African Americans. Journal of the American Society of Nephrology : Jasn. 24: 125-35. PMID 23243213 DOI: 10.1681/Asn.2012070713  0.481
2013 Isakova T, Xie H, Messinger S, Cortazar F, Scialla JJ, Guerra G, Contreras G, Roth D, Burke GW, Molnar MZ, Mucsi I, Wolf M. Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 13: 100-10. PMID 23025566 DOI: 10.1111/J.1600-6143.2012.04281.X  0.306
2013 Leaf DE, Wolf M. A physiologic-based approach to the evaluation of a patient with hyperphosphatemia. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 330-6. PMID 22938849 DOI: 10.1053/j.ajkd.2012.06.026  0.3
2013 Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 67-73. PMID 22883134 DOI: 10.1053/J.Ajkd.2012.06.022  0.431
2013 Houston J, Smith K, Isakova T, Sowden N, Wolf M, Gutiérrez OM. Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 23: 12-20. PMID 22406119 DOI: 10.1053/J.Jrn.2011.12.009  0.503
2013 Houston J, Isakova T, Wolf M. Phosphate Metabolism and Fibroblast Growth Factor 23 in Chronic Kidney Disease Nutritional Management of Renal Disease. 285-308. DOI: 10.1016/B978-0-12-391934-2.00020-5  0.331
2012 Jüppner H, Wolf M. αKlotho: FGF23 coreceptor and FGF23-regulating hormone. The Journal of Clinical Investigation. 122: 4336-9. PMID 23187136 DOI: 10.1172/Jci67055  0.35
2012 Isakova T, Wolf M. Partial answers from partial Klotho deficiency. Journal of the American Society of Nephrology : Jasn. 23: 1599-601. PMID 22975670 DOI: 10.1681/Asn.2012080848  0.381
2012 Ciancio G, Sageshima J, Chen L, Gaynor JJ, Hanson L, Tueros L, Montenora-Velarde E, Gomez C, Kupin W, Guerra G, Mattiazzi A, Fornoni A, Pugliese A, Roth D, Wolf M, et al. Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12: 3363-76. PMID 22946986 DOI: 10.1111/J.1600-6143.2012.04235.X  0.357
2012 Mangos S, Amaral AP, Faul C, Jüppner H, Reiser J, Wolf M. Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 27: 4314-22. PMID 22885518 DOI: 10.1093/Ndt/Gfs335  0.716
2012 Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM. Effects of phosphate binders in moderate CKD. Journal of the American Society of Nephrology : Jasn. 23: 1407-15. PMID 22822075 DOI: 10.1681/Asn.2012030223  0.388
2012 deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, Wolf M, Gaggin H, Januzzi J. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clinical Chemistry. 58: 1342-51. PMID 22791885 DOI: 10.1373/Clinchem.2012.185322  0.43
2012 Leaf DE, Wolf M, Waikar SS, Chase H, Christov M, Cremers S, Stern L. FGF-23 levels in patients with AKI and risk of adverse outcomes. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 1217-23. PMID 22700885 DOI: 10.2215/Cjn.00550112  0.443
2012 Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney International. 82: 737-47. PMID 22622492 DOI: 10.1038/Ki.2012.176  0.531
2012 Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M, et al. Fibroblast growth factor 23 and Inflammation in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 1155-62. PMID 22554719 DOI: 10.2215/Cjn.13281211  0.396
2012 Scialla JJ, Appel LJ, Wolf M, Yang W, Zhang X, Sozio SM, Miller ER, Bazzano LA, Cuevas M, Glenn MJ, Lustigova E, Kallem RR, Porter AC, Townsend RR, Weir MR, et al. Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 22: 379-388.e1. PMID 22480598 DOI: 10.1053/J.Jrn.2012.01.026  0.434
2012 Wahl P, Xie H, Scialla J, Anderson CA, Bellovich K, Brecklin C, Chen J, Feldman H, Gutierrez OM, Lash J, Leonard MB, Negrea L, Rosas SE, Anderson AH, Townsend RR, ... Wolf M, et al. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care. 35: 994-1001. PMID 22446176 DOI: 10.2337/Dc11-2235  0.428
2012 Nielsen SE, Reinhard H, Zdunek D, Hess G, Gutiérrez OM, Wolf M, Parving HH, Jacobsen PK, Rossing P. Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. Diabetes Research and Clinical Practice. 97: 71-6. PMID 22402306 DOI: 10.1016/J.Diabres.2012.02.007  0.327
2012 Wahl P, Wolf M. FGF23 in chronic kidney disease. Advances in Experimental Medicine and Biology. 728: 107-25. PMID 22396166 DOI: 10.1007/978-1-4614-0887-1_8  0.514
2012 Isakova T, Xie H, Barchi-Chung A, Smith K, Sowden N, Epstein M, Collerone G, Keating L, Jüppner H, Wolf M. Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 820-8. PMID 22383746 DOI: 10.2215/Cjn.11721111  0.413
2012 Gutiérrez OM, Smith KT, Barchi-Chung A, Patel NM, Isakova T, Wolf M. (1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 139-45. PMID 22246283 DOI: 10.2215/Cjn.06240611  0.382
2012 Kanbay M, Wolf M, Selcoki Y, Solak Y, Ikizek M, Uysal S, Segall L, Armutcu F, Eryonucu B, Duranay M, Goldsmith D, Covic A. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. International Urology and Nephrology. 44: 1169-75. PMID 22130958 DOI: 10.1007/S11255-011-0076-X  0.479
2012 Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, Mucsi I, Wolf M. Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12: 379-87. PMID 22054244 DOI: 10.1111/J.1600-6143.2011.03826.X  0.324
2012 Amaral AP, Oskouei B, Hu M, Moe O, Kuro-o M, Brand M, Hare J, Wolf M, Faul C. Fibroblast Growth Factor 23 Induces Left Ventricular Hypertrophy Journal of the American College of Cardiology. 59. DOI: 10.1016/S0735-1097(12)61060-2  0.755
2011 Gutiérrez OM, Wolf M, Taylor EN. Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 2871-8. PMID 22034506 DOI: 10.2215/Cjn.02740311  0.471
2011 Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, ... ... Wolf M, et al. FGF23 induces left ventricular hypertrophy. The Journal of Clinical Investigation. 121: 4393-408. PMID 21985788 DOI: 10.1172/Jci46122  0.771
2011 Scialla JJ, Leonard MB, Townsend RR, Appel L, Wolf M, Budoff MJ, Chen J, Lustigova E, Gadegbeku CA, Glenn M, Hanish A, Raj D, Rosas SE, Seliger SL, Weir MR, et al. Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 2612-9. PMID 21940840 DOI: 10.2215/Cjn.03910411  0.344
2011 Block GA, Wolf M. Phosphate REINs in the renoprotective benefit of ACE inhibition. Journal of the American Society of Nephrology : Jasn. 22: 1777-9. PMID 21903991 DOI: 10.1681/Asn.2011080833  0.383
2011 Isakova T, Xie H, Barchi-Chung A, Vargas G, Sowden N, Houston J, Wahl P, Lundquist A, Epstein M, Smith K, Contreras G, Ortega L, Lenz O, Briones P, Egbert P, ... ... Wolf M, et al. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 2688-95. PMID 21903990 DOI: 10.2215/Cjn.04290511  0.478
2011 Wolf M. Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone? Seminars in Dialysis. 24: 428-30. PMID 21851405 DOI: 10.1111/J.1525-139X.2011.00914.X  0.408
2011 Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, ... ... Wolf M, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. Jama. 305: 2432-9. PMID 21673295 DOI: 10.1001/Jama.2011.826  0.492
2011 Wolf M, Molnar MZ, Amaral AP, Czira ME, Rudas A, Ujszaszi A, Kiss I, Rosivall L, Kosa J, Lakatos P, Kovesdy CP, Mucsi I. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. Journal of the American Society of Nephrology : Jasn. 22: 956-66. PMID 21436289 DOI: 10.1681/Asn.2010080894  0.751
2011 Wu-Wong JR, Chen YW, Nakane M, Wolf M. Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 25: 215-22. PMID 21424825 DOI: 10.1007/S10557-011-6287-7  0.37
2011 Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, ... ... Wolf M, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney International. 79: 1370-8. PMID 21389978 DOI: 10.1038/Ki.2011.47  0.511
2011 Isakova T, Anderson CA, Leonard MB, Xie D, Gutiérrez OM, Rosen LK, Theurer J, Bellovich K, Steigerwalt SP, Tang I, Anderson AH, Townsend RR, He J, Feldman HI, Wolf M, et al. Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 1258-65. PMID 21382989 DOI: 10.1093/Ndt/Gfr026  0.47
2011 Kovesdy CP, Mucsi I, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Kim SJ, Wolf M, Molnar MZ. Association of serum phosphorus level with anemia in kidney transplant recipients. Transplantation. 91: 875-82. PMID 21358369 DOI: 10.1097/Tp.0B013E3182111Edf  0.407
2011 Seeherunvong W, Wolf M. Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation. Pediatric Transplantation. 15: 37-46. PMID 20946192 DOI: 10.1111/j.1399-3046.2010.01405.x  0.309
2011 Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 21: 295-302. PMID 20817560 DOI: 10.1053/J.Jrn.2010.07.002  0.422
2011 Isakova T, Gutiérrez OM, Smith K, Epstein M, Keating LK, Jüppner H, Wolf M. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 584-91. PMID 20631407 DOI: 10.1093/Ndt/Gfq419  0.44
2011 Gutiérrez OM, Isakova T, Enfield G, Wolf M. Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 21: 140-8. PMID 20537917 DOI: 10.1053/J.Jrn.2010.03.001  0.347
2011 Houston J, Isakova T, Smith K, Sowden N, Wahl P, Wolf M, Gutiérrez O. 122 Relationships Between FGF23, Dietary Phosphorus, Urinary Phosphate and Vascular Stiffness American Journal of Kidney Diseases. 57. DOI: 10.1053/J.Ajkd.2011.02.125  0.319
2010 Gutiérrez OM, Anderson C, Isakova T, Scialla J, Negrea L, Anderson AH, Bellovich K, Chen J, Robinson N, Ojo A, Lash J, Feldman HI, Wolf M. Low socioeconomic status associates with higher serum phosphate irrespective of race. Journal of the American Society of Nephrology : Jasn. 21: 1953-60. PMID 20847142 DOI: 10.1681/Asn.2010020221  0.387
2010 Wolf M. FGF23: fashion or physiology? Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1727-9. PMID 20847097 DOI: 10.2215/Cjn.07410810  0.488
2010 Jüppner H, Wolf M, Salusky IB. FGF-23: More than a regulator of renal phosphate handling? Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 2091-7. PMID 20593414 DOI: 10.1002/Jbmr.170  0.506
2010 Zisman AL, Wolf M. Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease. Current Opinion in Nephrology and Hypertension. 19: 335-42. PMID 20583336 DOI: 10.1097/MNH.0b013e328338f536  0.372
2010 Gutiérrez OM, Isakova T, Smith K, Epstein M, Patel N, Wolf M. Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 25: 3970-7. PMID 20530498 DOI: 10.1093/Ndt/Gfq316  0.418
2010 Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. Journal of the American Society of Nephrology : Jasn. 21: 1427-35. PMID 20507943 DOI: 10.1681/ASN.2009121293  0.422
2010 Szczech LA, Bregman DB, Harrington RA, Morris D, Butcher A, Koch TA, Goodnough LT, Wolf M, Onken JE. Randomized Evaluation of efficacy and safety of ferric carboxymaltose in Patients with iron deficiency Anaemia and Impaired Renal function (REPAIR-IDA): Rationale and study design Nephrology Dialysis Transplantation. 25: 2368-2375. PMID 20466657 DOI: 10.1093/Ndt/Gfq218  0.36
2010 Bhan I, Dubey A, Wolf M. Diagnosis and management of mineral metabolism in CKD. Journal of General Internal Medicine. 25: 710-6. PMID 20352364 DOI: 10.1007/S11606-010-1316-Y  0.387
2010 Patel NM, Gutiérrez OM, Andress DL, Coyne DW, Levin A, Wolf M. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney International. 77: 715-20. PMID 20130525 DOI: 10.1038/Ki.2009.551  0.366
2010 Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, Jüppner H. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. The Journal of Clinical Endocrinology and Metabolism. 95: 578-85. PMID 19965919 DOI: 10.1210/Jc.2009-1603  0.487
2010 Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CJ, Hoffmann U, Jacques PF, Booth SL, Vasan RS, Wolf M, Wang TJ. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 59: 242-8. PMID 19833894 DOI: 10.2337/Db09-1011  0.318
2010 Warsch JRL, Wolf M, Wright CB. Chronic kidney disease in patients with cognitive impairment: A marker of microvascular damage or an independent risk factor? Aging Health. 6: 423-427. DOI: 10.2217/Ahe.10.47  0.35
2010 Isakova T, Gutiérrez OM, Wolf M. Response to 'Targeting hyperphosphatemia: truth or dare' Kidney International. 77: 257. DOI: 10.1038/Ki.2009.448  0.301
2009 Wolf M. Second chances in mineral metabolism. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1-3. PMID 20007676 DOI: 10.2215/Cjn.08131109  0.4
2009 Wolf M. Fibroblast growth factor 23 and the future of phosphorus management. Current Opinion in Nephrology and Hypertension. 18: 463-8. PMID 19770756 DOI: 10.1097/MNH.0b013e328331a8c8  0.341
2009 Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney International. 76: 977-83. PMID 19657329 DOI: 10.1038/ki.2009.288  0.365
2009 Isakova T, Gutiérrez OM, Wolf M. A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. Kidney International. 76: 705-16. PMID 19606082 DOI: 10.1038/Ki.2009.246  0.436
2009 Friedman DJ, Afkarian M, Tamez H, Bhan I, Isakova T, Wolf M, Ankers E, Ye J, Tonelli M, Zoccali C, Kuro-o M, Moe O, Karumanchi SA, Thadhani R. Klotho variants and chronic hemodialysis mortality Journal of Bone and Mineral Research. 24: 1847-1855. PMID 19419323 DOI: 10.1359/Jbmr.090516  0.4
2009 Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 119: 2545-52. PMID 19414634 DOI: 10.1161/Circulationaha.108.844506  0.471
2009 Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, Gutierrez OM, Wolf M, Chang Y, Stossel TP, Thadhani R. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. Journal of the American Society of Nephrology : Jasn. 20: 1140-8. PMID 19389844 DOI: 10.1681/Asn.2008091008  0.331
2009 Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M. Phosphorus binders and survival on hemodialysis. Journal of the American Society of Nephrology : Jasn. 20: 388-96. PMID 19092121 DOI: 10.1681/Asn.2008060609  0.367
2008 Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. The New England Journal of Medicine. 359: 584-92. PMID 18687639 DOI: 10.1056/Nejmoa0706130  0.488
2008 Gutiérrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, Januzzi JL, Chang Y, Thadhani R. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clinical Chemistry. 54: 1339-1348. PMID 18539645 DOI: 10.1373/Clinchem.2007.101691  0.329
2008 Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from Nonuremic Causes: A Systematic Review Clinical Journal of the American Society of Nephrology. 3: 1139-1143. PMID 18417747 DOI: 10.2215/Cjn.00530108  0.389
2008 Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R. Impact of activated vitamin D and race on survival among hemodialysis patients. Journal of the American Society of Nephrology : Jasn. 19: 1379-88. PMID 18400938 DOI: 10.1681/Asn.2007091002  0.324
2008 Gutiérrez OM, Isakova T, Andress DL, Levin A, Wolf M. Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease Kidney International. 73: 956-962. PMID 18256597 DOI: 10.1038/Ki.2008.4  0.411
2008 Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. Journal of the American Society of Nephrology : Jasn. 19: 615-23. PMID 18216315 DOI: 10.1681/Asn.2007060673  0.465
2008 Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 117: 503-11. PMID 18180395 DOI: 10.1161/Circulationaha.107.706127  0.329
2007 Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Tonelli M, Thadhani R. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney International. 72: 1004-13. PMID 17687259 DOI: 10.1038/Sj.Ki.5002451  0.342
2007 Wolf M, Thadhani R. Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. The Journal of Steroid Biochemistry and Molecular Biology. 103: 487-90. PMID 17197169 DOI: 10.1016/J.Jsbmb.2006.11.009  0.335
2006 Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SM, Jüppner H, Wolf M. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney International. 70: 1486-94. PMID 16941023 DOI: 10.1038/Sj.Ki.5001788  0.349
2005 Wolf M, Thadhani R. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease. Seminars in Dialysis. 18: 302-6. PMID 16076353 DOI: 10.1111/J.1525-139X.2005.18406.X  0.374
2005 Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Jüppner H, Wolf M. Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney Disease Journal of the American Society of Nephrology. 16: 2205-2215. PMID 15917335 DOI: 10.1681/Asn.2005010052  0.511
2005 Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA, Thadhani R. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. Journal of the American Society of Nephrology : Jasn. 16: 1115-25. PMID 15728786 DOI: 10.1681/Asn.2004070573  0.323
2004 Wieland A, Mehta A, Greenfield A, Wolf M. Temporary suprarenal inferior vena cava filter for renal biopsy in a patient with renal vein thrombosis. Clinical Nephrology. 62: 239-241. PMID 15481858 DOI: 10.5414/Cnp62239  0.322
2003 Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. The New England Journal of Medicine. 349: 446-56. PMID 12890843 DOI: 10.1056/Nejmoa022536  0.343
2002 Thadhani R, Wolf M, West ML, Tonelli M, Ruthazer R, Pastores GM, Obrador GT. Patients with Fabry disease on dialysis in the United States. Kidney International. 61: 249-55. PMID 11786107 DOI: 10.1046/J.1523-1755.2002.00097.X  0.352
Low-probability matches (unlikely to be authored by this person)
2011 Ibrahim M, Sany D, Bichari W, El Shahawy Y, Awadalla A, Weekers L, Warling X, Moonen M, Smelten N, Medart L, Krzesinski J, Cavalier E, Delanaye P, Ketteler M, Martin KJ, ... ... Wolf M, et al. Dialysis / Mineral bone disease 1 Clinical Kidney Journal. 4: 4.s2.13-4.s2.13. DOI: 10.1093/Ndtplus/4.S2.13  0.299
2015 Arora P, Song Y, Dusek J, Plotnikoff G, Sabatine MS, Cheng S, Valcour A, Swales H, Taylor B, Carney E, Guanaga D, Young JR, Karol C, Torre M, Azzahir A, ... ... Wolf M, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 131: 254-62. PMID 25359163 DOI: 10.1161/Circulationaha.114.011732  0.297
2012 Ketteler M, Martin KJ, Wolf M, Amdahl M, Cozzolino M, Goldsmith D, Sharma A, Marx S, Khan S. Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 27: 3270-8. PMID 22387567 DOI: 10.1093/Ndt/Gfs018  0.297
2011 Ketteler M, Martin K, Cozzolino M, Goldsmith D, Sharma A, Wolf M, Khan S, Amdahl M, Dumas E, Audhya P. 141 Baseline Characteristics of Subjects in Impact-Shpt: A Study to Evaluate the Efficacy and Safety of Paricalcitol and Cinacalcet in Hemodialysis Patients With Secondary Hyperparathyroidism American Journal of Kidney Diseases. 57. DOI: 10.1053/J.Ajkd.2011.02.144  0.296
2015 Faul C, Wolf M. Hunt for the culprit of cardiovascular injury in kidney disease. Cardiovascular Research. PMID 26395966 DOI: 10.1093/Cvr/Cvv228  0.295
2007 Thadhani R, Wolf M. Vitamin D in patients with kidney disease: cautiously optimistic. Advances in Chronic Kidney Disease. 14: 22-6. PMID 17200040 DOI: 10.1053/j.ackd.2006.10.009  0.294
2021 Cohen JB, Yang W, Li L, Zhang X, Zheng Z, Orlandi P, Bansal N, Deo R, Lash JP, Rahman M, He J, Shafi T, Chen J, Cohen DL, Matsushita K, ... ... Wolf M, et al. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 34052355 DOI: 10.1053/j.ajkd.2021.03.021  0.294
2021 Shi M, Grabner A, Wolf M. Importance of Extra-Renal CYP24A1 Expression for Maintaining Mineral Homeostasis Journal of the Endocrine Society. 5: A234-A234. DOI: 10.1210/jendso/bvab048.476  0.293
2011 Wahl P, Isakova T, Wolf M. 344 Disordered Mineral Metabolism in CKD: Earlier Onset & Greater Severity of Diabetes American Journal of Kidney Diseases. 57. DOI: 10.1053/J.Ajkd.2011.02.347  0.292
2023 Grabner A, Fuchs M, Burke E, Latic N, Murray S, Li H, Sparks M, Abraham D, Zhang H, Rosenberg P, Hänzelmann S, Hausmann F, Huber T, Erben R, Fisher-Wellman K, ... ... Wolf M, et al. Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease. Research Square. PMID 38196615 DOI: 10.21203/rs.3.rs-3705543/v1  0.292
2016 Robinson-Cohen C, Lutsey PL, Kleber ME, Nielson CM, Mitchell BD, Bis JC, Eny KM, Portas L, Eriksson J, Lorentzon M, Koller DL, Milaneschi Y, Teumer A, Pilz S, Nethander M, ... ... Wolf M, et al. Genetic Variants Associated with Circulating Parathyroid Hormone. Journal of the American Society of Nephrology : Jasn. PMID 27927781 DOI: 10.1681/Asn.2016010069  0.291
2018 Ix J, Isakova T, Larive B, Raphael K, Raj D, Cheung A, Sprague S, Fried L, Gassman J, Middleton J, Flessner M, Block G, Wolf M. FP803EFFECTS OF NICOTINAMIDE AND LANTHANUM CARBONATE ON SERUM PHOSPHATE AND FGF23 CONCENTRATIONS IN CHRONIC KIDNEY DISEASE: PRIMARY RESULTS OF THE COMBINE TRIAL Nephrology Dialysis Transplantation. 33: i634-i634. DOI: 10.1093/NDT/GFY146.FP803  0.29
2013 Rangel ML, Alghamdi I, Contreras G, Harrington T, Thomas DB, Barisoni L, Andrews D, Wolf M, Asif A, Nayer A. Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. Lupus. 22: 855-64. PMID 23722230 DOI: 10.1177/0961203313491024  0.289
2020 Bhandari S, Kalra PA, Berkowitz M, Belo D, Thomsen LL, Wolf M. Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 32049331 DOI: 10.1093/Ndt/Gfaa011  0.286
2004 Thadhani R, Ecker JL, Mutter WP, Wolf M, Smirnakis KV, Sukhatme VP, Levine RJ, Karumanchi SA. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension. 43: 988-92. PMID 15023932 DOI: 10.1161/01.Hyp.0000124460.67539.1D  0.286
2012 Gutiérrez OM, Katz R, Peralta CA, de Boer IH, Siscovick D, Wolf M, Diez Roux A, Kestenbaum B, Nettleton JA, Ix JH. Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 22: 480-9. PMID 22217539 DOI: 10.1053/J.Jrn.2011.08.008  0.285
2010 Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O'Reilly PF, Houston DK, Glazer NL, ... ... Wolf M, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 376: 180-8. PMID 20541252 DOI: 10.1016/S0140-6736(10)60588-0  0.284
2023 Fuchs MA, Wolf M. Renal proximal tubule cells: power and finesse. The Journal of Clinical Investigation. 133. PMID 37115697 DOI: 10.1172/JCI169607  0.282
2010 Leaf DE, Wolf M, Stern L. Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury Nephrology Dialysis Transplantation. 25: 1335-1337. PMID 20037176 DOI: 10.1093/ndt/gfp682  0.281
2010 Isakova T, Gutiérrez O, Smith K, Epstein M, Patel N, Jüppner H, Wolf M. 137: Short-Term Effect of Dietary Phosphorus Restriction and Lanthanum Carbonate on FGF23 in Chronic Kidney Disease Patients American Journal of Kidney Diseases. 55: B66. DOI: 10.1053/j.ajkd.2010.02.144  0.278
2016 Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 27561289 DOI: 10.2215/CJN.02110216  0.277
2018 Block G, Block M, Smits G, Kooienga L, Mehta R, Isakova T, Wolf M, Chertow G. LB05RANDOMIZED TRIAL OF THE EFFECTS OF FERRIC CITRATE IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE Nephrology Dialysis Transplantation. 33: i637-i638. DOI: 10.1093/ndt/gfy146.LB05  0.277
2014 Mariani LH, White MT, Shults J, Anderson CA, Feldman HI, Wolf M, Reese PP, Denburg MR, Townsend RR, Lo JC, Cappola AR, Carlow D, Gadegbeku CA, Steigerwalt S, Leonard MB, et al. Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 24: 186-93. PMID 24613295 DOI: 10.1053/J.Jrn.2014.01.015  0.276
2011 Carvalho C, Isakova T, Collerone G, Olbina G, Wolf M, Westerman M, Gutiérrez OM. Hepcidin and disordered mineral metabolism in chronic kidney disease. Clinical Nephrology. 76: 90-8. PMID 21762639 DOI: 10.5414/CN107018  0.276
2014 Wolf M. In search of the fountain of youth. Journal of the American Society of Nephrology : Jasn. 25: 2143-5. PMID 24854281 DOI: 10.1681/Asn.2014040392  0.276
2023 Edmonston D, Sparks M, Rajagopal S, Wolf M. Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction. Kidney360. PMID 36978225 DOI: 10.34067/KID.0000000000000103  0.275
2020 Hofacker SA, Dupre ME, Vellano K, McNally B, Starks MA, Wolf M, Svetkey LP, Pun PH. Association between Patient Race and Staff Resuscitation Efforts After Cardiac Arrest in Outpatient Dialysis Clinics: a study from the CARES Surveillance Group. Resuscitation. PMID 32860854 DOI: 10.1016/J.Resuscitation.2020.07.036  0.274
2014 Portale AA, Wolf M, Jüppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB. Disordered FGF23 and mineral metabolism in children with CKD. Clinical Journal of the American Society of Nephrology : Cjasn. 9: 344-53. PMID 24311704 DOI: 10.2215/CJN.05840513  0.274
2024 Hsu S, Bansal N, Denburg M, Ginsberg C, Hoofnagle AN, Isakova T, Ix JH, Robinson-Cohen C, Wolf M, Kestenbaum BR, de Boer IH, Zelnick LR. Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 38477777 DOI: 10.1093/jbmr/zjae021  0.273
2022 Bundy JD, Rahman M, Matsushita K, Jaeger BC, Cohen JB, Chen J, Deo R, Dobre MA, Feldman HI, Flack J, Kallem RR, Lash JP, Seliger S, Shafi T, Weiner SJ, ... Wolf M, et al. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. Journal of the American Society of Nephrology : Jasn. PMID 35145041 DOI: 10.1681/ASN.2021060747  0.271
2004 Wolf M, Hubel CA, Seely EW, Roberts JM, Sukhatme VP, Karumanchi SA, Thadhani R. 34 Preeclampsia And Future Cardiovascular Disease: Potential Role Of Altered Angiogenesis And Insulin Resistance. Journal of Investigative Medicine. 52. DOI: 10.1136/Jim-52-Suppl2-108  0.268
2023 Murray SL, Wolf M. Calcium and Phosphate Disorders: Core Curriculum 2024. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 38099870 DOI: 10.1053/j.ajkd.2023.04.017  0.266
2020 Lucas A, Wolf M. Health Outcomes With Vitamin D Supplementation-Reply. Jama. 323: 1619. PMID 32343326 DOI: 10.1001/Jama.2020.2645  0.265
2003 Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care. 26: 819-24. PMID 12610043 DOI: 10.2337/Diacare.26.3.819  0.265
2005 Wolf M, Shah A, Lam C, Martinez A, Smirnakis KV, Epstein FH, Taylor RN, Ecker JL, Karumanchi SA, Thadhani R. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. American Journal of Obstetrics and Gynecology. 193: 16-22. PMID 16021053 DOI: 10.1016/J.Ajog.2005.03.016  0.265
2003 Thadhani R, Wolf M, Hsu-Blatman K, Sandler L, Nathan D, Ecker JL. First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. American Journal of Obstetrics and Gynecology. 189: 171-6. PMID 12861158 DOI: 10.1067/Mob.2003.343  0.264
2019 Edmonston D, Wolf M. Good Guys, Bad Guys, Guesses, and Near Misses in Nephrology. Clinical Journal of the American Society of Nephrology : Cjasn. 14: 7-9. PMID 30559107 DOI: 10.2215/Cjn.13801118  0.263
2007 Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, Cuckle H, Wolf M. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. American Journal of Obstetrics and Gynecology. 197: 35.e1-7. PMID 17618748 DOI: 10.1016/J.Ajog.2007.02.025  0.263
2007 Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL. Predicting gestational diabetes: choosing the optimal early serum marker. American Journal of Obstetrics and Gynecology. 196: 410.e1-6; discussion. PMID 17403439 DOI: 10.1016/J.Ajog.2006.12.011  0.262
2011 Wang TJ, Zhang F, Richards JB, Kestenbaum B, Van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O'Reilly PF, Houston DK, Glazer NL, ... ... Wolf M, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study Obstetrical and Gynecological Survey. 66: 91-93. DOI: 10.1097/Ogx.0B013E318216B03D  0.262
2020 Grau L, Gitomer B, McNair B, Wolf M, Harris P, Brosnahan G, Torres V, Steinman T, Yu A, Chapman A, Chonchol M, Nowak KL. Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease. Kidney360. 1: 648-656. PMID 33305291 DOI: 10.34067/Kid.0001692020  0.261
2001 Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstetrics and Gynecology. 98: 757-62. PMID 11704165 DOI: 10.1016/S0029-7844(01)01551-4  0.261
2010 Isakova T, Wolf MS. FGF23 or PTH: which comes first in CKD ? Kidney International. 78: 947-9. PMID 21030968 DOI: 10.1038/ki.2010.281  0.261
2015 Wolf M. Mineral (Mal)Adaptation to Kidney Disease-Young Investigator Award Address: American Society of Nephrology Kidney Week 2014. Clinical Journal of the American Society of Nephrology : Cjasn. 10: 1875-85. PMID 26350436 DOI: 10.2215/CJN.04430415  0.26
2020 Bansal N, Zelnick LR, Soliman E, Anderson A, Christenson R, DeFilippi C, Deo R, Feldman HI, He J, Ky B, Kusek J, Lash J, Seliger S, Shafi T, Wolf M, et al. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 33309861 DOI: 10.1053/j.ajkd.2020.09.021  0.259
2019 Lucas A, Wolf M. Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials. Jama. PMID 31703117 DOI: 10.1001/Jama.2019.17302  0.258
2021 Paul S, Wong M, Akhabue E, Mehta RC, Kramer H, Isakova T, Carnethon MR, Wolf M, Gutiérrez OM. Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults. Journal of the American Heart Association. e020196. PMID 34387090 DOI: 10.1161/JAHA.120.020196  0.258
2017 Kim SJ, Cheresh P, Eren M, Jablonski RP, Yeldandi A, Ridge KM, Budinger GS, Kim DH, Wolf MS, Vaughan D, Kamp DW. Klotho, an anti-aging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis. American Journal of Physiology. Lung Cellular and Molecular Physiology. ajplung.00063.2017. PMID 28428174 DOI: 10.1152/Ajplung.00063.2017  0.257
2020 Perelló J, Ferrer MD, Del Mar Pérez M, Kaesler N, Brandenburg V, Behets GJ, D'Haese PC, Garg R, Isern B, Gold A, Wolf M, Salcedo C. Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis. British Journal of Pharmacology. PMID 32557649 DOI: 10.1111/Bph.15163  0.256
2017 Ishigami J, Jaar BG, Rebholz CM, Grams ME, Michos ED, Wolf M, Kovesdy CP, Uchida S, Coresh J, Lutsey PL, Matsushita K. Biomarkers of Mineral and Bone Metabolism and 20-year Risk for Hospitalization with Infection: the ARIC Study. The Journal of Clinical Endocrinology and Metabolism. PMID 29029099 DOI: 10.1210/Jc.2017-01868  0.252
2005 Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G, Markovic N. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta. 26: 563-73. PMID 15993706 DOI: 10.1016/J.Placenta.2004.09.001  0.25
2023 Hsu S, Zelnick LR, Bansal N, Brown J, Denburg M, Feldman HI, Ginsberg C, Hoofnagle AN, Isakova T, Leonard MB, Lidgard B, Robinson-Cohen C, Wolf M, Xie D, Kestenbaum BR, et al. Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association. e028561. PMID 37421259 DOI: 10.1161/JAHA.122.028561  0.25
2020 Edmonston DL, Isakova T, Dember LM, Brunelli S, Young A, Brosch R, Beddhu S, Chakraborty H, Wolf M. Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients on Maintenance Hemodialysis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 33279558 DOI: 10.1053/j.ajkd.2020.10.008  0.249
2022 Garg G, Tedla YG, Ghosh AS, Mohottige D, Kolak M, Wolf M, Kho A. Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 36058428 DOI: 10.1053/j.ajkd.2022.07.008  0.249
2023 Edmonston D, Isakova T, Wolf M. Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease. Journal of the American Heart Association. 12: e029785. PMID 37609990 DOI: 10.1161/JAHA.123.029785  0.249
2020 Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, Thomsen LL, Carpenter TO, Weber T, Brandenburg V, Zoller H. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. Jama. 323: 432-443. PMID 32016310 DOI: 10.1001/Jama.2019.22450  0.244
2013 Wolf M. Contemporary Mineral Metabolism for Clinicians and Scientists: Introduction Seminars in Nephrology. 33: 91-92. PMID 23465496 DOI: 10.1016/J.Semnephrol.2012.12.010  0.243
2007 Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, Markovic N, Thadhani R, Luft FC, Dechend R. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension. 49: 612-7. PMID 17210828 DOI: 10.1161/01.Hyp.0000256565.20983.D4  0.24
2005 Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker J. Predicting gestational diabetes: Which is the best early serum marker? American Journal of Obstetrics and Gynecology. 193: S90. DOI: 10.1016/J.Ajog.2005.10.302  0.239
2011 Wolf M, Bushinsky DA. The beehive and the merry-go-round in mineral metabolism. Current Opinion in Nephrology and Hypertension. 20: 329-30. PMID 21654389 DOI: 10.1097/Mnh.0B013E328347C0B4  0.238
2018 Prasad PV, Li W, Raj DS, Carr J, Carr M, Thacker J, Li LP, Wang C, Sprague SM, Ix JH, Chonchol M, Block G, Cheung AK, Raphael K, Gassman J, Wolf M, et al. Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD. Kidney International Reports. 3: 1467-1472. PMID 30450473 DOI: 10.1016/J.Ekir.2018.07.006  0.238
2003 Colussi G, Kida Y, Ratnam S, Kaw D, Rao P, Wolf M, Teng M, Thadhani R. Paricalcitol, Calcitriol, and Survival of Patients Undergoing Hemodialysis [2] (multiple letters) The New England Journal of Medicine. 349: 1971-1972. PMID 14614175 DOI: 10.1056/Nejm200311133492018  0.235
2021 Mehta R, Cho ME, Cai X, Lee J, Chen J, He J, Flack J, Shafi T, Saraf SL, David V, Feldman HI, Isakova T, Wolf M. Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease. Kidney International. PMID 34339746 DOI: 10.1016/j.kint.2021.07.013  0.234
2020 Edmonston DL, Rajagopal S, Wolf M. Echocardiography to Screen for Pulmonary Hypertension in CKD. Kidney International Reports. 5: 2275-2283. PMID 33305121 DOI: 10.1016/j.ekir.2020.09.033  0.234
2004 Wolf M, Sauk J, Shah A, Vossen Smirnakis K, Jimenez-Kimble R, Ecker JL, Thadhani R. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care. 27: 21-7. PMID 14693961 DOI: 10.2337/Diacare.27.1.21  0.229
2018 Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W. Randomized trial of intravenous iron-induced hypophosphatemia. Jci Insight. 3. PMID 30518682 DOI: 10.1172/Jci.Insight.124486  0.229
2009 Hackenbeck T, Huber R, Schietke R, Knaup KX, Klanke B, Warnecke C, Eckardt K, Wiesener M, Zhou Q, Nie J, Wang X, Fan J, Yu X, Chan JSD, Brezniceanu M, ... ... Wolf M, et al. Cell signalling and cell growth control - 1 Ndt Plus. 2. DOI: 10.1093/Ndtplus/2.S2.19  0.228
2021 Glaspy JA, Wolf M, Strauss WE. Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome. Advances in Therapy. PMID 34053011 DOI: 10.1007/s12325-021-01770-2  0.228
2017 Middleton JP, Wolf M. Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic. Jama. 317: 139-141. PMID 28097342 DOI: 10.1001/Jama.2016.18631  0.228
2006 Polu KR, Wolf M. Clinical problem-solving. Needle in a haystack. The New England Journal of Medicine. 354: 68-73. PMID 16394304 DOI: 10.1056/Nejmcps051939  0.227
2024 Panzer M, Meindl E, Schaefer B, Wagner S, Glodny B, Mayer G, Pircher A, Schwarz C, Beckmann F, Hejny C, Joachim-Mrosko B, Konzett J, Tilg H, Heidegger I, Wolf M, et al. Intravenous iron-induced hypophosphatemia and kidney stone disease. Bone Reports. 21: 101759. PMID 38590391 DOI: 10.1016/j.bonr.2024.101759  0.227
2016 Bushinsky DA, Wolf M. Mineral metabolism: progress in the face of complexity. Current Opinion in Nephrology and Hypertension. 25: 269-70. PMID 27253147 DOI: 10.1097/Mnh.0000000000000242  0.224
2010 Gutiérrez OM, Wolf M. Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies. Seminars in Dialysis. 23: 401-6. PMID 20557490 DOI: 10.1111/j.1525-139X.2010.00750.x  0.223
2013 Wolf M, Bushinsky DA. Innovations in bones and stones. Current Opinion in Nephrology and Hypertension. 22: 369-70. PMID 23666418 DOI: 10.1097/Mnh.0B013E3283622Bd4  0.222
2020 Wolf M, Schaefer B, Zoller H. Persistent Hypophosphatemia after Ferric Carboxymaltose Is Associated with Persistent Changes in Biomarkers of Bone Metabolism Blood. 136: 13-14. DOI: 10.1182/blood-2020-134435  0.219
2007 Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine. 167: 1159-65. PMID 17563024 DOI: 10.1001/archinte.167.11.1159  0.219
2021 Edmonston DL, Matsouaka R, Shah SH, Rajagopal S, Wolf M. Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload. The American Journal of Cardiology. PMID 34497006 DOI: 10.1016/j.amjcard.2021.08.016  0.217
2020 Roberts JK, Seay NW, Mohottige D, Zaas A, Wolf M. The Nephrology Immersion Classroom for Internal Medicine Residents Kidney. DOI: 10.34067/Kid.0001882020  0.216
2021 Murray SL, Wolf M. Pivoting From PTH to FGF23 to Mend Breaking Hearts on Dialysis. Circulation Research. 128: 1626-1628. PMID 34043423 DOI: 10.1161/CIRCRESAHA.121.319306  0.214
2005 Smirnakis KV, Chasan-Taber L, Wolf M, Markenson G, Ecker JL, Thadhani R. Postpartum diabetes screening in women with a history of gestational diabetes. Obstetrics and Gynecology. 106: 1297-303. PMID 16319255 DOI: 10.1097/01.Aog.0000189081.46925.90  0.213
2013 Wolf M, Koch TA, Bregman DB. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 1793-803. PMID 23505057 DOI: 10.1002/Jbmr.1923  0.213
2019 Musgrove J, Wolf M. Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia. Alimentary Pharmacology & Therapeutics. 50: 609-610. PMID 31414533 DOI: 10.1111/Apt.15437  0.209
2003 Ecker J, Shah A, Wolf M, Smirnakis K, Sauk J, Jimenez-Kimble R, Thadhani R. High leukocyte count portends development of gestational diabetes mellitus American Journal of Obstetrics and Gynecology. 189: S107. DOI: 10.1016/J.Ajog.2003.10.159  0.208
2020 Ghuman J, Cai X, Patel R, Khan S, Hecktman J, Redfield M, Lewis G, Shah SJ, Wolf M, Isakova T, Mehta R. Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction. Journal of Cardiac Failure. PMID 33035687 DOI: 10.1016/j.cardfail.2020.09.477  0.207
2003 Sauk I, Wolf M, Shah A, Smirnakis K, Jimenez-Kimble R, Ecker JL, Thadhani R. Inflammation And Glucose Intolerance: A Prospective Study Of Gestational Diabetes Mellitus. Journal of Investigative Medicine. 51: 338-338. DOI: 10.1136/Jim-51-06-24  0.207
2017 Schaefer B, Glodny B, Wolf M, Zoller H. Letter: inconsistency in reporting of hypophosphatemia after intravenous iron. Alimentary Pharmacology & Therapeutics. 46: 641-643. PMID 28805320 DOI: 10.1111/Apt.14231  0.204
2017 Wolf M, Bushinsky DA. Something old, something new, something borrowed, something black. Current Opinion in Nephrology and Hypertension. PMID 28375872 DOI: 10.1097/Mnh.0000000000000325  0.202
2001 Sandler L, Wolf M, Hsu K, Munoz K, Thadhani R, Ecker J. 336 First trimester sex hormone binding globulin values predict later preeclampsia in lean women American Journal of Obstetrics and Gynecology. 185. DOI: 10.1016/S0002-9378(01)80367-7  0.201
2018 Kolak M, Bradley M, Block DR, Pool L, Garg G, Toman CK, Boatright K, Lipiszko D, Koschinsky J, Kershaw K, Carnethon M, Isakova T, Wolf M. Urban foodscape trends: Disparities in healthy food access in Chicago, 2007-2014. Health & Place. 52: 231-239. PMID 30015180 DOI: 10.1016/J.Healthplace.2018.06.003  0.201
2019 Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, et al. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association. 8: e012200. PMID 31379242 DOI: 10.1161/Jaha.119.012200  0.2
2023 Raphael KL, Katz R, Larive B, Kendrick C, Isakova T, Sprague S, Wolf M, Raj DS, Fried LF, Gassman J, Hoofnagle A, Cheung AK, Ix JH. Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial. Journal of the American Society of Nephrology : Jasn. 35: 57-65. PMID 38170601 DOI: 10.1681/ASN.0000000000000264  0.199
2021 Wang AA, Cai X, Srivastava A, Prasad PV, Sprague SM, Carr J, Wolf M, Ix JH, Block GA, Chonchol M, Raphael KL, Cheung AK, Raj DS, Gassman JJ, Rahsepar AA, et al. Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE Trial. Kidney360. 3: 258-268. PMID 35373122 DOI: 10.34067/KID.0005022021  0.197
2013 Ketteler M, Wolf M, Hahn K, Ritz E. Phosphate: a novel cardiovascular risk factor. European Heart Journal. 34: 1099-101. PMID 23045267 DOI: 10.1093/eurheartj/ehs247  0.195
2022 Dream S, Kuo LE, Kuo JH, Sprague SM, Nwariaku FE, Wolf M, Olson JA, Moe SM, Lindeman B, Chen H. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism. Annals of Surgery. PMID 35848728 DOI: 10.1097/SLA.0000000000005522  0.194
2021 Bello AK, McIsaac M, Okpechi IG, Johnson DW, Jha V, Harris DCH, Saad S, Zaidi D, Osman MA, Ye F, Lunney M, Jindal K, Klarenbach S, Kalantar-Zadeh K, Kovesdy CP, ... ... Wolf M, et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean. Kidney International Supplements. 11: e66-e76. PMID 33981472 DOI: 10.1016/j.kisu.2021.01.001  0.194
2023 Cowan AC, Clemens KK, Sontrop JM, Dixon SN, Killin L, Anderson S, Acedillo RR, Bagga A, Bohm C, Brown PA, Cote B, Dev V, Harris C, Hiremath S, Kiaii M, ... ... Wolf M, et al. Magnesium and Fracture Risk in the General Population and Patients Receiving Dialysis: A Narrative Review. Canadian Journal of Kidney Health and Disease. 10: 20543581231154183. PMID 36814964 DOI: 10.1177/20543581231154183  0.192
2004 Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. The Journal of Clinical Endocrinology and Metabolism. 89: 770-5. PMID 14764795 DOI: 10.1210/jc.2003-031244  0.192
2017 Pichler G, Haller M, Kainz A, Wolf M, Redon J, Oberbauer R. [BP.07.07] PROGNOSTIC VALUE OF BONE- AND VASCULAR DERIVED MOLECULAR BIOMARKERS IN HEMODIALYSIS AND RENAL TRANSPLANT PATIENTS Journal of Hypertension. 35: e265-e266. DOI: 10.1097/01.hjh.0000523773.76575.26  0.189
2005 Wolf M, Rose H, Smith RN. Case records of the Massachusetts General Hospital. Case 28-2005. A 42-year-old man with weight loss, weakness, and a rash. The New England Journal of Medicine. 353: 1148-57. PMID 16162886 DOI: 10.1056/Nejmcpc059022  0.187
2018 Gerber C, Cai X, Lee J, Craven T, Scialla J, Souma N, Srivastava A, Mehta R, Paluch A, Hodakowski A, Frazier R, Carnethon MR, Wolf MS, Isakova T. Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29798889 DOI: 10.2215/Cjn.11871017  0.185
2012 Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, Kritchevsky SB, Cauley JA, Tanaka T, Ferrucci L, Bandinelli S, Patel KV, Hagström E, Michaëlsson K, Melhus H, ... ... Wolf M, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. Jama. 308: 1898-905. PMID 23150009 DOI: 10.1001/Jama.2012.17304  0.183
2014 Wald R, Goldstein MB, Wald RM, Harel Z, Kirpalani A, Perl J, Yuen DA, Wolf MS, Yan AT. Correlates of left ventricular mass in chronic hemodialysis recipients. The International Journal of Cardiovascular Imaging. 30: 349-56. PMID 24293047 DOI: 10.1007/s10554-013-0337-0  0.178
2000 Wolf M. Case of the month misdiagnosis [1] (multiple letters) American Journal of Medicine. 108: 263. PMID 10723985 DOI: 10.1016/S0002-9343(99)00403-9  0.176
2016 Portale AA, Wolf M, Jüppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB. Disordered FGF23 and mineral metabolism in children with CKD World Review of Nutrition and Dietetics. 114: 94-96. DOI: 10.1159/000441813  0.172
2024 Trujillo J, Alotaibi M, Seif N, Cai X, Larive B, Gassman J, Raphael KL, Cheung AK, Raj DS, Fried LF, Sprague S, Block G, Chonchol M, Middleton JP, Wolf M, et al. Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with Chronic Kidney Disease. Kidney360. PMID 38570905 DOI: 10.34067/KID.0000000000000437  0.168
2014 Bushinsky DA, Wolf M. The pursuit of truth and beauty. Current Opinion in Nephrology and Hypertension. 23: 329-30. PMID 24840299 DOI: 10.1097/01.Mnh.0000447025.97464.Ea  0.162
2017 Batacchi Z, Robinson-Cohen C, Hoofnagle AN, Isakova T, Kestenbaum B, Martin KJ, Wolf MS, de Boer IH. Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 28768705 DOI: 10.2215/Cjn.00530117  0.159
2008 Wolf M, Thadhani R. Response to ‘Vitamin D levels and early mortality among incident hemodialysis patients’ Kidney International. 74: 389. DOI: 10.1038/ki.2008.172  0.156
2019 Schrauben SJ, Hsu JY, Wright Nunes J, Fischer MJ, Srivastava A, Chen J, Charleston J, Steigerwalt S, Tan TC, Fink JC, Ricardo AC, Lash JP, Wolf M, Feldman HI, Anderson AH, et al. Health Behaviors in Younger and Older Adults With CKD: Results From the CRIC Study. Kidney International Reports. 4: 80-93. PMID 30596171 DOI: 10.1016/j.ekir.2018.09.003  0.152
2017 Scialla JJ, Asplin J, Wolf M. The Authors Reply. Kidney International. 91: 1518-1519. PMID 28501306 DOI: 10.1016/J.Kint.2017.02.020  0.15
2002 Wolf M, Sandler L, Jimenez-Kimble R, Shah A, Ecker JL, Thadhani R. Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension. 40: 886-91. PMID 12468574 DOI: 10.1161/01.HYP.0000042085.65467.9F  0.148
2020 Pool LR, Kershaw KN, Gordon-Larsen P, Gutiérrez OM, Reis JP, Isakova T, Wolf M, Carnethon MR. Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. PMID 32147284 DOI: 10.1053/J.Jrn.2020.01.020  0.146
2004 Wolf M, Shah A, Jimenez-Kimble R, Sauk J, Ecker JL, Thadhani R. Differential risk of hypertensive disorders of pregnancy among Hispanic women. Journal of the American Society of Nephrology : Jasn. 15: 1330-8. PMID 15100374 DOI: 10.1097/01.ASN.0000125615.35046.59  0.145
2021 Schaefer B, Tobiasch M, Wagner S, Glodny B, Tilg H, Wolf M, Zoller H. Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management. Bone. 154: 116202. PMID 34534708 DOI: 10.1016/j.bone.2021.116202  0.145
2018 Nakayama M, Tani Y, Zhu WJ, Watanabe K, Yokoyama K, Fukagawa M, Akiba T, Wolf M, Hirakata H. Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide. Kidney International Reports. 3: 364-373. PMID 29725640 DOI: 10.1016/j.ekir.2017.10.016  0.135
2021 Hsu CY, Yang W, Parikh RV, Anderson AH, Chen TK, Cohen DL, He J, Mohanty MJ, Lash JP, Mills KT, Muiru AN, Parsa A, Saunders MR, Shafi T, Townsend RR, ... ... Wolf M, et al. Race, Genetic Ancestry, and Estimating Kidney Function in CKD. The New England Journal of Medicine. PMID 34554660 DOI: 10.1056/NEJMoa2103753  0.131
2004 Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, Rajakumar A, Daftary A, Shakir AS, Seely EW, Roberts JM, Sukhatme VP, Karumanchi SA, Thadhani R. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. The Journal of Clinical Endocrinology and Metabolism. 89: 6239-43. PMID 15579783 DOI: 10.1210/Jc.2004-0548  0.127
2022 Zoller H, Wolf M, Blumenstein I, Primas C, Lindgren S, Thomsen LL, Reinisch W, Iqbal T. Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial. Gut. PMID 36343979 DOI: 10.1136/gutjnl-2022-327897  0.119
2022 Ratziu V, Harrison SA, Loustaud-Ratti V, Bureau C, Lawitz E, Abdelmalek M, Alkhouri N, Francque S, Girma H, Darteil R, Couchoux H, Wolf M, Sanyal A, Vonderscher J, Scalfaro P. Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH. Journal of Hepatology. PMID 36334688 DOI: 10.1016/j.jhep.2022.10.023  0.117
2021 Schaefer B, Zoller H, Wolf M. Risk factors for and effects of persistent and severe hypophosphatemia following ferric carboxymaltose. The Journal of Clinical Endocrinology and Metabolism. PMID 34850000 DOI: 10.1210/clinem/dgab852  0.115
2002 Wolf M, Sandler L, Muñoz K, Hsu K, Ecker JL, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study. The Journal of Clinical Endocrinology and Metabolism. 87: 1563-8. PMID 11932283 DOI: 10.1210/jcem.87.4.8405  0.114
2008 Wolf M. Active vitamin D and survival. Journal of the American Society of Nephrology : Jasn. 19: 1442-3. PMID 18614769 DOI: 10.1681/ASN.2008060595  0.107
2023 Pao AC, Shahzad SR, Song S, Ganesan C, Conti S, Leppert J, Cheung AK, Ix JH, Isakova T, Wolf M, Raj DS, Sprague SM, Fried LF, Gassman J, Fong P, et al. Response to Alkali Administration in Women and Men With and Without CKD. Kidney Medicine. 5: 100670. PMID 37492113 DOI: 10.1016/j.xkme.2023.100670  0.106
2022 Murray SL, Wolf M. Exercising the FGF23-Cardiac Axis. Kidney360. 3: 1471-1473. PMID 36245659 DOI: 10.34067/KID.0004962022  0.102
2012 Vincenti F, Vincenti F, Weir M, Von Visger J, Kopyt N, Mannon R, Tseng S, Goodman W, Wolf M, Aires I, Aires I, Ferreira A, Silva C, Remedio F, Nolasco F. Bone and mineral metabolism after transplantation Nephrology Dialysis Transplantation. 27: ii8-ii8. DOI: 10.1093/NDT/GFS218  0.094
2012 Bushinsky DA, Wolf MS. Mineral metabolism: confusion to clarity. Current Opinion in Nephrology and Hypertension. 21: 353-4. PMID 22622652 DOI: 10.1097/MNH.0b013e3283546fec  0.09
2020 Schaefer B, Tobiasch M, Viveiros A, Tilg H, Kennedy NA, Wolf M, Zoller H. Hypophosphatemia after Treatment of Iron Deficiency with Intravenous Ferric Carboxymaltose or Iron Isomaltoside - A Systematic Review and Meta-Analysis. British Journal of Clinical Pharmacology. PMID 33188534 DOI: 10.1111/bcp.14643  0.086
2023 Wolf M. Matryoshka hormones. Blood. 142: 7-9. PMID 37410509 DOI: 10.1182/blood.2023020770  0.084
2019 Wolf M, Rubin J, Achebe M, Econs M, Peacock M, Imel E, Thomsen L, Carpenter T, Weber T, Zoller H. OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxymaltose on Hormonal Control of Phosphate Homeostasis: The PHOSPHARE-IDA04/05 Randomized Controlled Trials Journal of the Endocrine Society. 3. DOI: 10.1210/JS.2019-OR13-3  0.082
2018 Edmonston D, Wolf M, Pencina M. Statins at Dialysis Transition-Supportive but Not Sufficient. Jama Network Open. 1: e182411. PMID 30646212 DOI: 10.1001/jamanetworkopen.2018.2411  0.08
2020 Lentz TA, Curtis LH, Rockhold FW, Martin D, Andersson TLG, Arias C, Berlin JA, Binns C, Cook A, Cziraky M, Dent R, Desai M, Emmett A, Esserman D, George J, ... ... Wolf M, et al. Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting. Therapeutic Innovation & Regulatory Science. PMID 32514736 DOI: 10.1007/S43441-020-00175-7  0.075
2015 Wolf M, Bushinsky DA. Bones and stones, edition 2015. Current Opinion in Nephrology and Hypertension. 24: 301-2. PMID 26050114 DOI: 10.1097/MNH.0000000000000143  0.073
2020 Wolf M, Auerbach M, Kalra PA, Glaspy J, Thomsen LL, Bhandari S. Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials. American Journal of Hematology. PMID 33027541 DOI: 10.1002/ajh.26015  0.068
2023 Martens KL, Wolf M. Incidence, mechanism, and consequences of IV iron-induced hypophosphatemia. Hematology. American Society of Hematology. Education Program. 2023: 636-639. PMID 38066924 DOI: 10.1182/hematology.2023000521  0.063
2012 Bernstein EJ, Isakova T, Sullivan ME, Chibnik LB, Bazari H, Wolf MS, Kay J. Hypophosphatemia is associated with nephrogenic systemic fibrosis: a case-control study Annals of the Rheumatic Diseases. 71: A72.1-A72. DOI: 10.1136/annrheumdis-2011-201237.26  0.06
2006 Verlohren S, Wolf M, Wallukat G, Herse F, Hubel C, Dudenhausen J, Dechend R. Presence of activating autoantibodies against the AT1-Receptor in women with a history of preeclampsia Geburtshilfe Und Frauenheilkunde. 66. DOI: 10.1055/s-2006-952894  0.048
2002 Wolf M. Clinical research career development: The individual perspective Academic Medicine. 77: 1084-1088. PMID 12431916 DOI: 10.1097/00001888-200211000-00004  0.042
2020 Roberts JK, Seay NW, Mohottige D, Zaas A, Wolf M. The Nephrology Immersion Classroom for Internal Medicine Residents. Kidney360. 1: 1060-1067. PMID 35368792 DOI: 10.34067/KID.0001882020  0.035
2022 Roberts JK, Schub M, Singhal S, Norwood J, Cassini T, Hudler A, Ramadurai D, Smith CC, Desai SS, Weintraub J, Hasler SH, Schwiesow TM, Connors GR, Didwania A, Hargett CW, ... Wolf M, et al. Exploring US internal medicine resident career preferences: a Q-methodology study. Advances in Health Sciences Education : Theory and Practice. PMID 36264447 DOI: 10.1007/s10459-022-10172-0  0.035
2005 Smirnakis KV, Martinez A, Blatman KH, Wolf M, Ecker JL, Thadhani R. Early pregnancy insulin resistance and subsequent gestational diabetes mellitus. Diabetes Care. 28: 1207-8. PMID 15855591 DOI: 10.2337/diacare.28.5.1207  0.035
2009 Oxnard GR, Zinkus TM, Bazari H, Wolf M. Integrating research training into residency: tools of human investigation. Academic Medicine : Journal of the Association of American Medical Colleges. 84: 1295-300. PMID 19707076 DOI: 10.1097/ACM.0b013e3181b18861  0.031
2018 Kolak M, Bradley M, Block D, Pool L, Garg G, Toman CK, Boatright K, Lipiszko D, Koschinsky J, Kershaw K, Carnethon M, Isakova T, Wolf M. Chicago supermarket data and food access analytics in census tract shapefiles for 2007-2014. Data in Brief. 21: 2482-2488. PMID 30560157 DOI: 10.1016/J.Dib.2018.11.014  0.03
Hide low-probability matches.